It’s time for a greater role for pharmacists in asthma management

I’ve returned from a Saturday morning in community pharmacy practice and am reflecting on the number of patients I saw with asthma. I checked...

Beyond politics; patient groups and the art of influence

“What is a patient group?”, a friend of mine enquired during one of our recent regular political discussions. It struck me afterwards that given...

The real cost of over the counter prescriptions

  NHS England recently published its guidance for CCGs on the over the counter (OTC) items which should not be routinely prescribed in primary care...

David wants understanding between NHS & industry

Not who you say I am: Pharma companies need to be clear who they’re talking to and why they’re talking to them. Last week a pharma...

Two takes: Bad habits – help or hindrance?

  In this month’s emotive opinion battle, we ask two healthcare professionals if we should be encouraging patients to evaluate their lifestyle choices, or are...

Pharmacists are the last step between HCPs and patients

Having the right medicine at the right time and administered in the right way can be the difference between that patient continuing their treatment...

AI is launching healthcare into the future

With tales of Victorian era conditions on hospital wards, chronic ambulance queues and surgery delays reminiscent of the NHS’s nadir in the early 1990s,...

Does a pharmacy career appeal to young people?

  For pharmacy graduates forcing doors open is essential. Over 30 years ago I made the decision to study pharmacy at Nottingham University, with little understanding...

Tracking progress of the Rare Disease Strategy

February’s magazine focused on rare diseases, but how can implementation plans for the Rare Disease Strategy be properly monitored? The Rare Disease Strategy implementation plans...

Outcome-based contracts for medicines: What’s the deal?

  Outcome-based contracts for medicines – is there enough financial headroom to attract pharma? In the January and February issues of Pf Magazine we discussed the...

Latest articles

Maxwellia makes two new appointments

Maxwellia expand their team with two new appointments

Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator. 
BMS & Boston Medical Center enter collaboration

BMS & Boston Medical Center announce research collaboration

BMS & Boston Medical Center enter research collaboration to investigate markers of immuno-oncology response and resistance Bristol-Myers Squibb Company...
Syringe with liquid

EC approves KEYTRUDA® as adjuvant therapy

MSD (Merck in the U.S. and Canada) has announced that the European Commission has approved its anti-PD-1 therapy, KEYTRUDA (pembrolizumab), for the adjuvant treatment...